STAND. COM. REP. NO. 3028

 

Honolulu, Hawaii

                  

 

RE:    H.B. No. 2600

       H.D. 2

 

 

 

Honorable Shan S. Tsutsui

President of the Senate

Twenty-Sixth State Legislature

Regular Session of 2012

State of Hawaii

 

Sir:

 

     Your Committees on Health and Public Safety, Government Operations, and Military Affairs, to which was referred H.B. No. 2600, H.D. 2, entitled:

 

"A BILL FOR AN ACT RELATING TO CONTROLLED SUBSTANCES,"

 

beg leave to report as follows:

 

     The purpose and intent of this measure is to update the Uniform Controlled Substances Act, chapter 329, Hawaii Revised Statutes, to make it consistent with federal laws on controlled substances.

 

     Your Committees received testimony in support of this measure from the Department of Public Safety and Honolulu Police Department.

 

     Your Committees find that there is a pressing societal problem involving synthetic hallucinogenic substances, which are being developed for sale to the public and marketed as "herbal incense" or "bath salts".  Your Committees find that due to the ever-growing list of synthetic hallucinogenic substances, updating the schedule of controlled substances with a general chemical class will prevent manufacturers from simply adding an isomer on to an existing controlled substance to make it a new non-controlled compound, and that consequently, this approach is the most effective means by which to control illegal substances and ensure public safety.

 

     As affirmed by the records of votes of the members of your Committees on Health and Public Safety, Government Operations, and Military Affairs that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 2600, H.D. 2, and recommend that it pass Second Reading and be placed on the calendar for Third Reading.

 

Respectfully submitted on behalf of the members of the Committees on Health and Public Safety, Government Operations, and Military Affairs,

 

____________________________

WILL ESPERO, Chair

 

____________________________

JOSH GREEN, M.D., Chair